查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1446514

雄性脫髮症(AGA) 市場規模、佔有率、趨勢分析報告：按性別、治療、最終用途、銷售管道、細分市場預測，2024-2030 年

Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Gender (Male, Female), By Treatment (Pharmaceuticals, Devices), By End-use (Dermatology Clinics, Homecare Settings), By Sales Channel, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

雄性脫髮症(AGA) 市場成長與趨勢：

Grand View Research最新報告預測，到2030年，全球雄性脫髮症（AGA）市場規模預計將達到47.6億美元，2024年至2030年複合年成長率為8.45%。

雄性脫髮症（AGA）盛行率的增加是推動市場成長的關鍵因素之一。美國脫髮協會公佈的資料顯示，男性脫髮中95%以上是由雄性脫髮症（AGA）引起的。男性脫髮的發生率隨著老齡化而增加。根據國際毛髮修復外科學會發表的報告，對於男性來說，40%的掉髮發生在35歲時，65%的掉髮發生在60歲時，70%的掉髮發生在80歲時，80%的掉髮發生在85歲時。就會出現脫髮的情況。

此外，市場成長歸因於技術進步，包括引入低強度雷射治療以促進頭髮生長。同樣，多雷射梳和頭髮按摩器或刷子的推出也推動了市場的發展。例如，Lifemax 紅外線髮刷、Follinex 按摩梳、Hairmax 雷射梳是市場上一些技術先進的產品。在大多數臨床環境中，採用非剝脫性雷射療法和局部塗布的聯合治療來取得更好的效果。雷射設備產生的微小傷口創造了良好的創傷治療環境，促進毛髮生長。

此外，癌症等慢性病盛行率的增加預計將為市場成長提供有利可圖的機會。例如，根據 Globocan 的最新報告，2020 年全球癌症發生率估計為 19,288,916 人。為癌症治療患者開出的某些藥物也會導致掉髮。例如，化療藥物、放射線治療、荷爾蒙療法、免疫治療等都有可能誘發脫髮、頭髮稀疏。預計未來 20 年癌症發生率將增加約 70%，從而推動市場成長。

然而，雄性脫髮症（AGA）治療的報銷是該市場的主要挑戰之一。大多數 AGA治療方法，並非醫療必需的，因此通常不在保險承保範圍內。 AGA 治療的自付額通常包括經常看醫生、處方藥的自付額以及手術的共同保險。脫髮症不是一種危及生命的疾病，因此其報銷情況很複雜。例如，Aetna Inc. 的脫髮症政策規定，針對輕度病症的藥物與針對嚴重病症的藥物不同。此外，落建（米諾地爾）不屬於該計劃的涵蓋範圍，因為它被視為一種實驗性治療。因此，缺乏治療報銷政策限制了市場的成長。

雄性脫髮症(AGA) 市場報告亮點

  • 由於雄性脫髮症(AGA) 治療的採用率較高，男性細分市場在 2023 年佔據市場主導地位。
  • 2023年，醫藥板塊佔最大佔有率。產品核可數量的增加、製藥公司投資的增加以及社會對採用藥物治療雄激素性脫髮症(AGA) 的態度的改變預計將在該細分市場的成長中發揮重要作用。
  • 預計設備治療領域在預測期內將以最快的複合年成長率成長。
  • 由於消費者對處方藥和雷射技術等最新治療方法的認知不斷提高，加上強大的產品平臺，皮膚科診所最終用途細分市場在 2023 年佔據了最大的收益佔有率。
  • 由於高疾病盛行率、消費者意識、積極的政府措施、技術進步和醫療保健基礎設施的改善，北美在 2023 年佔據了主要的銷售佔有率。
  • 2023年11月，Sun Pharma高級研究公司（SPARC）與約翰霍普金斯大學和捷克研究機構IOCB就SCD-153簽訂了獨家授權合約，其中包括IOCB擁有的所有專利。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章 雄性脫髮症(AGA) 市場：變數、趨勢、範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
  • 雄性脫髮症(AGA) 市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
  • 雄性脫髮症(AGA) 市場：按地區分類的盛行率資料
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲 (MEA)

第4章雄性脫髮症（AGA）市場：性別估計和趨勢分析

  • 2023 年和 2030 年按性別分類的市場佔有率
  • 細分儀表板
  • 按性別分類的全球雄性脫髮症(AGA) 市場展望
  • 2018年至2030年市場規模、預測與趨勢分析

第5章雄性脫髮症（AGA）市場：治療估計與趨勢分析

  • 2023年及2030年治療市場佔有率
  • 細分儀表板
  • 全球雄性脫髮症(AGA) 治療市場展望
  • 2018年至2030年市場規模、預測與趨勢分析

第6章雄性脫髮症（AGA）市場：最終用途估計和趨勢分析

  • 2023 年及 2030 年最終用途市場佔有率
  • 細分儀表板
  • 按最終用途分類的全球雄性脫髮症(AGA) 市場展望
  • 2018年至2030年市場規模、預測與趨勢分析

第7章雄性脫髮症（AGA）市場：銷售管道估計與趨勢分析

  • 2023年及2030年銷售管道市場佔有率
  • 細分儀表板
  • 按銷售管道分類的全球雄性脫髮症(AGA) 市場展望
  • 2018年至2030年市場規模、預測與趨勢分析

第8章雄性脫髮症（AGA）市場：區域估計和趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概述
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商形勢
    • Johnson &Johnson Services, Inc.
    • Cipla, Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Merck &Co., Inc.
    • Dr. Reddy's Laboratories Ltd.
    • Aurobindo Pharma
    • Lexington Intl., LLC
    • Freedom Laser Therapy, Inc.（iRESTORE Hair Growth System）
    • Curallux, LLC
    • Apira Science, Inc.（iGROW Laser）
    • Theradome, Inc.
Product Code: GVR-4-68040-197-2

Androgenetic Alopecia Market Growth & Trends:

The global androgenetic alopecia market size is anticipated to reach USD 4.76 billion by 2030 and is anticipated to expand at a CAGR of 8.45% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing prevalence of androgenetic alopecia is one of the crucial factors driving the market growth. According to data published by the American Hair Loss Association, over 95% of hair loss in men is caused due to androgenetic alopecia. The occurrence of hair loss in men increases proportionately with age. On the basis of the report published by the International Society of Hair Restoration Surgery, in men, it is estimated that 40% of hair loss is encountered by the age of 35 years, 65% at 60 years, 70% at 80 years, and 80% at the age of 85 years.

Moreover, the market growth can be attributed to advancements in technology, including the introduction of a low-level laser therapy, which helps stimulate hair growth. Likewise, the introduction of several laser combs and hair massagers or brushes is also boosting the market. For instance, Lifemax Infrared Hairbrush, Follinex Massager Comb, and Hairmax Laser Comb are some of the technologically advanced products available in the market. Most clinical-based settings offer combination therapy of non-ablative laser treatment and topical application of medicinal products for better results. Microscopic injuries created by laser devices create a favorable wound-healing environment that triggers hair regrowth.

Furthermore, the increasing incidence of chronic diseases such as cancer is anticipated to offer lucrative opportunities for market growth. For instance, according to the latest report by Globocan, the incidence of cancer was estimated to be 19,288,916 in 2020 globally. Certain medications prescribed to patients for the treatment of cancer are also responsible for hair loss. For instance, chemotherapeutic agents, radiation therapy, hormone therapy, and immunotherapy are more likely to induce hair loss or hair thinning. Cancer incidence is expected to rise by about 70% over the next two decades, thus driving the market growth.

However, reimbursement coverage for androgenetic alopecia treatment is one of the major challenges in this market. Since most treatment modalities for AGA are considered cosmetic procedures and not medically essential ones, they are generally not covered under insurance. Out-of-pocket costs for AGA treatment usually include frequent doctor visits, prescription drug copays, and coinsurance for procedures. Alopecia has complex reimbursement positioning, as it is not a life-threatening disease. For instance, Aetna Inc.'s policy for alopecia states that drugs covered for mild conditions are different from those considered for more severe conditions. In addition, the scheme does not cover Rogaine (minoxidil) as it is considered an experimental therapy. Thus, lack of reimbursement policies for treatment is restraining the market growth.

Androgenetic Alopecia Market Report Highlights:

  • The male segment dominated the market in 2023 due to the high adoption of androgenetic alopecia treatments
  • The pharmaceuticals segment held the largest share in 2023. The increasing number of product approvals, rising investments by pharmaceutical companies, and shift in societal attitude toward adopting pharmaceutical drugs for the treatment of androgenetic alopecia are likely to play a prominent role in segment growth
  • The devices treatment segment is expected to grow at the fastest CAGR over the forecast period
  • The dermatology clinics end-use segment accounted for the largest revenue share in 2023 owing to increased consumer awareness regarding prescription medicines & modern treatments, such as laser technology, coupled with a strong product pipeline
  • North America held a dominant revenue share in 2023 due to the high disease prevalence, consumer awareness, proactive government measures, technological advancements, and improvements in healthcare infrastructure
  • In November 2023, Sun Pharma Advanced Research Company (SPARC) entered into an agreement with Johns Hopkins and the Czech research institute IOCB to exclusively license SCD-153, including all patents owned by IOCB

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Gender
    • 1.2.2. Treatment
    • 1.2.3. End Use
    • 1.2.4. Sales Channel
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in Asia Pacific
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Gender outlook
    • 2.2.2. Treatment outlook
    • 2.2.3. End use outlook
    • 2.2.4. Sales channel outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Androgenetic Alopecia Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of androgenic alopecia
      • 3.2.1.2. Technological advancements in androgenic alopecia
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of reimbursement policies for androgenic alopecia
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Increasing prevalence of chronic diseases
  • 3.3. Androgenetic Alopecia Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. Androgenetic Alopecia Market: Prevalence Data, By Region
    • 3.4.1. North America
      • 3.4.1.1. U.S.
      • 3.4.1.2. Canada
    • 3.4.2. Europe
      • 3.4.2.1. UK
      • 3.4.2.2. Germany
      • 3.4.2.3. France
      • 3.4.2.4. Italy
      • 3.4.2.5. Spain
      • 3.4.2.6. Denmark
      • 3.4.2.7. Sweden
      • 3.4.2.8. Norway
    • 3.4.3. Asia Pacific
      • 3.4.3.1. Japan
      • 3.4.3.2. China
      • 3.4.3.3. India
      • 3.4.3.4. South Korea
      • 3.4.3.5. Australia
      • 3.4.3.6. Thailand
    • 3.4.4. Latin America
      • 3.4.4.1. Brazil
      • 3.4.4.2. Mexico
      • 3.4.4.3. Argentina
    • 3.4.5. Middle East and Africa (MEA)
      • 3.4.5.1. South Africa
      • 3.4.5.2. Saudi Arabia
      • 3.4.5.3. UAE
      • 3.4.5.4. Kuwait

Chapter 4. Androgenetic Alopecia Market: Gender Estimates & Trend Analysis

  • 4.1. Gender Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Androgenetic Alopecia Market by Gender Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Male
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Female
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Androgenetic Alopecia Market: Treatment Estimates & Trend Analysis

  • 5.1. Treatment Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Androgenetic Alopecia Market by Treatment Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Pharmaceuticals
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Devices
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Androgenetic Alopecia Market: End-use Estimates & Trend Analysis

  • 6.1. End-use Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Androgenetic Alopecia Market by End Use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Dermatology Clinics
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 6.4.2. Homecare Settings
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Androgenetic Alopecia Market: Sales Channel Estimates & Trend Analysis

  • 7.1. Sales Channel Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Androgenetic Alopecia Market by Sales Channel Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.4.1. Prescription
      • 7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. OTC
      • 7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Androgenetic Alopecia Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.5. North America
    • 8.5.1. U.S.
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 8.5.2. Canada
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 8.6. Europe
    • 8.6.1. UK
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 8.6.2. Germany
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 8.6.3. France
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 8.6.4. Italy
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework/ reimbursement structure
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 8.6.5. Spain
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework/ reimbursement structure
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 8.6.6. Norway
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework/ reimbursement structure
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 8.6.7. Sweden
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework/ reimbursement structure
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 8.6.8. Denmark
      • 8.6.8.1. Key country dynamics
      • 8.6.8.2. Regulatory framework/ reimbursement structure
      • 8.6.8.3. Competitive scenario
      • 8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 8.7. Asia Pacific
    • 8.7.1. Japan
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 8.7.2. China
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 8.7.3. India
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 8.7.4. Australia
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 8.7.5. South Korea
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework/ reimbursement structure
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 8.7.6. Thailand
      • 8.7.6.1. Key country dynamics
      • 8.7.6.2. Regulatory framework/ reimbursement structure
      • 8.7.6.3. Competitive scenario
      • 8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 8.8. Latin America
    • 8.8.1. Brazil
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework/ reimbursement structure
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 8.8.2. Mexico
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework/ reimbursement structure
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 8.8.3. Argentina
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework/ reimbursement structure
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 8.9. MEA
    • 8.9.1. South Africa
      • 8.9.1.1. Key country dynamics
      • 8.9.1.2. Regulatory framework/ reimbursement structure
      • 8.9.1.3. Competitive scenario
      • 8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 8.9.2. Saudi Arabia
      • 8.9.2.1. Key country dynamics
      • 8.9.2.2. Regulatory framework/ reimbursement structure
      • 8.9.2.3. Competitive scenario
      • 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 8.9.3. UAE
      • 8.9.3.1. Key country dynamics
      • 8.9.3.2. Regulatory framework/ reimbursement structure
      • 8.9.3.3. Competitive scenario
      • 8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 8.9.4. Kuwait
      • 8.9.4.1. Key country dynamics
      • 8.9.4.2. Regulatory framework/ reimbursement structure
      • 8.9.4.3. Competitive scenario
      • 8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2023
    • 9.3.4. Johnson & Johnson Services, Inc.
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Cipla, Inc.
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Sun Pharmaceutical Industries Ltd.
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Merck & Co., Inc.
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Dr. Reddy's Laboratories Ltd.
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Aurobindo Pharma
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Lexington Intl., LLC
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Freedom Laser Therapy, Inc. (iRESTORE Hair Growth System)
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. Curallux, LLC
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Product benchmarking
      • 9.3.12.4. Strategic initiatives
    • 9.3.13. Apira Science, Inc. (iGROW Laser)
      • 9.3.13.1. Company overview
      • 9.3.13.2. Financial performance
      • 9.3.13.3. Product benchmarking
      • 9.3.13.4. Strategic initiatives
    • 9.3.14. Theradome, Inc.
      • 9.3.14.1. Company overview
      • 9.3.14.2. Financial performance
      • 9.3.14.3. Product benchmarking
      • 9.3.14.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America androgenetic alopecia market, by country, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Table 3 North America androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 4 North America androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 5 North America androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 6 North America androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 7 US androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 8 US androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 9 US androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 10 US androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 11 Canada androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 12 Canada androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 13 Canada androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Canada androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 15 Europe androgenetic alopecia market, by country, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Table 16 Europe androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 17 Europe androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 18 Europe androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 20 Germany androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 21 Germany androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 22 Germany androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Germany androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 24 UK androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 25 UK androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 26 UK androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 27 UK androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 28 France androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 29 France androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 30 France androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 31 France androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 32 Italy androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 33 Italy androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 34 Italy androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Italy androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 36 Spain androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 37 Spain androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 38 Spain androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Spain androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 40 Denmark androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 41 Denmark androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 42 Denmark androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Denmark androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 44 Sweden androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 45 Sweden androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 46 Sweden androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Sweden androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 48 Norway androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 49 Norway androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 50 Norway androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Norway androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific androgenetic alopecia market, by country, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Table 53 Asia Pacific androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 57 China androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 58 China androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 59 China androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 60 China androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 61 Japan androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 62 Japan androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 63 Japan androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 64 Japan androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 65 India androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 66 India androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 67 India androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 68 India androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 69 South Korea androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 70 South Korea androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 71 South Korea androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 72 South Korea androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 73 Australia androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 74 Australia androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 75 Australia androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Australia androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 77 Thailand androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 78 Thailand androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 79 Thailand androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 80 Thailand androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 81 Latin America androgenetic alopecia market, by country, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Table 82 Latin America androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 83 Latin America androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 84 Latin America androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Latin America androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 86 Brazil androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 87 Brazil androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 88 Brazil androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 89 Brazil androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 90 Mexico androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 91 Mexico androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 92 Mexico androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 93 Mexico androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 94 Argentina androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 95 Argentina androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 96 Argentina androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 97 Argentina androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 98 MEA androgenetic alopecia market, by country, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Table 99 MEA androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 100 MEA androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 101 MEA androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 102 MEA androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 103 South Africa androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 104 South Africa androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 105 South Africa androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 106 South Africa androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 111 UAE androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 112 UAE androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 113 UAE androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 114 UAE androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 115 Kuwait androgenetic alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 116 Kuwait androgenetic alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 117 Kuwait androgenetic alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 118 Kuwait androgenetic alopecia market, by sales channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Androgenetic alopecia market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Treatment and end-use segment snapshot
  • Fig. 10 Sales channel and gender segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Market dynamics
  • Fig. 13 Prevalence of rheumatoid arthritis in 2022, by WHO regions
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 Androgenetic alopecia market: Gender outlook and key takeaways
  • Fig. 17 Androgenetic alopecia market: Gender movement analysis
  • Fig. 18 Male market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Female market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Androgenetic alopecia market: Treatment outlook and key takeaways
  • Fig. 21 Androgenetic alopecia market: Treatment movement analysis
  • Fig. 22 Pharmaceuticals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Androgenetic alopecia market: End-use outlook and key takeaways
  • Fig. 25 Androgenetic alopecia market: End-use movement analysis
  • Fig. 26 Dermatology clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Homecare settings market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Androgenetic alopecia market: Sales channels outlook and key takeaways
  • Fig. 29 Androgenetic alopecia market: Sales channels movement analysis
  • Fig. 30 Prescription market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 OTC market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Androgenetic alopecia market revenue, by region, 2023 & 2030 (USD Million)
  • Fig. 33 Regional marketplace: Key takeaways (1/2)
  • Fig. 34 Regional marketplace: Key takeaways (2/2)
  • Fig. 35 North America androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 36 Key country dynamics
  • Fig. 37 U.S. androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 38 Key country dynamics
  • Fig. 39 Canada androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 40 Europe androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 41 Key country dynamics
  • Fig. 42 UK androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 43 Key country dynamics
  • Fig. 44 Germany androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 45 Key country dynamics
  • Fig. 46 France androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 47 Key country dynamics
  • Fig. 48 Spain androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 49 Key country dynamics
  • Fig. 50 Italy androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 51 Key country dynamics
  • Fig. 52 Denmark androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 53 Key country dynamics
  • Fig. 54 Sweden androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 55 Key country dynamics
  • Fig. 56 Norway androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 57 Rest of Europe androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 58 Asia Pacific androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 59 Key country dynamics
  • Fig. 60 Reimbursement scenario
  • Fig. 61 Japan androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 62 Key country dynamics
  • Fig. 63 Regulatory framework
  • Fig. 64 Reimbursement scenario
  • Fig. 65 China androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 66 Key country dynamics
  • Fig. 67 Reimbursement scenario
  • Fig. 68 India androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 69 Key country dynamics
  • Fig. 70 Australia androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 71 Key country dynamics
  • Fig. 72 South Korea androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 73 Key country dynamics
  • Fig. 74 Thailand androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 75 Key country dynamics
  • Fig. 76 Malaysia androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 77 Key country dynamics
  • Fig. 78 Vietnam androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 79 Key country dynamics
  • Fig. 80 Philippines androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 81 Rest of Asia Pacific androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 82 Latin America androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 83 Key country dynamics
  • Fig. 84 Brazil regulation details
  • Fig. 85 Reimbursement scenario
  • Fig. 86 Brazil androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 87 Key country dynamics
  • Fig. 88 Argentina pharmaceuticals registration details
  • Fig. 89 Argentina androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 90 Key country dynamics
  • Fig. 91 Regulatory framework
  • Fig. 92 Reimbursement scenario
  • Fig. 93 Mexico androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 94 Rest of Latin America androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 95 MEA androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 South Africa androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 98 Key country dynamics
  • Fig. 99 Saudi Arabia androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 100 Key country dynamics
  • Fig. 101 UAE androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 102 Key country dynamics
  • Fig. 103 Kuwait androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 104 Key country dynamics
  • Fig. 105 Turkey androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 106 Rest of MEA androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 108 Company market share analysis, 2023
  • Fig. 109 Strategic framework